FDA clears restricted return of MS drug
FDA clears restricted return of MS drug
AP via Yahoo! News Mon, 05 Jun 2006 10:36 AM PDT
A multiple sclerosis drug pulled from the market last year because of a rare but life-threatening side effect will return under a restricted distribution program, health officials said Monday.
US OKs resumed sales of Biogen and Elan's Tysabri
Reuters via Yahoo! News Mon, 05 Jun 2006 10:21 AM PDT
Biogen Idec Inc. and Elan Corp. won permission on Monday to resume sales of their multiple sclerosis drug Tysabri, which was withdrawn last year after it was linked to a rare but potentially fatal brain disease, U.S. regulators said.
AP via Yahoo! News Mon, 05 Jun 2006 10:36 AM PDT
A multiple sclerosis drug pulled from the market last year because of a rare but life-threatening side effect will return under a restricted distribution program, health officials said Monday.
US OKs resumed sales of Biogen and Elan's Tysabri
Reuters via Yahoo! News Mon, 05 Jun 2006 10:21 AM PDT
Biogen Idec Inc. and Elan Corp. won permission on Monday to resume sales of their multiple sclerosis drug Tysabri, which was withdrawn last year after it was linked to a rare but potentially fatal brain disease, U.S. regulators said.
posted by Bill at 3:26 AM
0 Comments:
Post a Comment
<< Home